G
Grace Therapeutics, Inc. (GRCE)
NCM – Real Time Price. Currency in USD
2.38
+0.01 (0.42%)
At close: Jun 26, 2026, 4:00 PM EDT
2.38
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:55 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.38
+0.01 (0.42%)
At close: Jun 26, 2026, 4:00 PM EDT
2.38
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:55 PM EDT
No Data
There are no news for this stock.
Cash reserves $17.0M barely cover the upcoming debt maturities $0.0
Total current assets $17.4M exceed Total current liabilities $2.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.10 | 6.05 | 10 | |
| Quick ratio | 8.10 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -124K | -11K | -7K | -7K | -7K |
| Operating Income | -18M | -11M | -17M | -11M | -11M |
| Net Income | -42M | -13M | -10M | -8M | -8M |
| EBITDA | -18M | -11M | -17M | -11M | -11M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 38.43 | 5.5 |
| Next quarter | N/A | -115.5 | 1.0 |
| Current year | N/A | -10.04 | 1.0 |
| Next year | N/A | -18.87 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 49.11 | 57.14 | 16.68 | 9.8 |
| Y/Y | 999 | -285.21 | -154.54 | 32.6 | 5.5 |
| 3y average | 999 | 37.94 | 52.77 | 14.1 | 9.5 |
| 5y average | 779.2 | -33.63 | -2.67 | 6.02 | 4.3 |
| Weighted average score | 7.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |